Ispire Collaborates with Berify and Chemular on Blockchain Technology

Business by 2FIRSTS.ai

Feb.23.2024

Ispire Collaborates with Berify and Chemular on Blockchain Technology

Ispire collaborates with Touchpoint World Wide Inc. and Chemular International Inc. to accelerate e-cigarette technology innovation in a new venture.

According to a report by UPI on February 22nd, Ispire (ISPIRE) has announced a partnership with Touchpoint World Wide Inc. (Berify, a platform specializing in linking physical products to the digital world, digital engagement, and brand protection) and Chemular International Inc to establish a joint venture.

This joint venture will focus on accelerating innovation in the e-cigarette technology sector, including the development of safe, user-friendly age verification and age restriction vaporized nicotine device solutions.

Inspire Technology Company's Co-CEO Michael Wang stated, "By combining our collective expertise in hardware, blockchain, and regulatory consulting, our goal is to set new standards for age verification, safety, and overall quality in the e-cigarette industry. We hope this joint venture will bring significant advancements in device control, safety, anti-counterfeiting, and enhanced user experience, ultimately improving overall market and consumer satisfaction."

References:

[1] Ispire, Berify and Chemular to Propel Innovation in Vape Hardware Manufacturing Industry

Also Read:

[1] ISPIRE Reports Strong Growth in Q2 FY2024: Operating Expenses Surge to $10.3 Million, Net Loss at $4 Million

[2] Joint Venture Between Ispire and Berify for PMTA and Software Development

#North America #United States #Open system e-cigarettes #Technology.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

ZYN Nicotine Pouches Seek MRTP Authorization; FDA Sets January Meeting

The U.S. FDA has scheduled a Tobacco Products Scientific Advisory Committee (TPSAC) meeting for January 22, 2026, to review Swedish Match USA’s Modified Risk Tobacco Product (MRTP) applications for 20 ZYN nicotine pouch products. Although the products gained PMTA authorization in early 2025, MRTP approval is required for marketing them with reduced-risk claims.

Nov.24 by 2FIRSTS.ai

Scandinavian Tobacco Group Reports Q3 2025 Results and Narrows Full-Year Guidance

Scandinavian Tobacco Group (STG) reported net sales of DKK 2.4 billion for Q3 2025, in line with last year. EBITDA before special items reached DKK 519 million with a 22.0% margin. Handmade Cigars and Next Generation Products saw organic growth, while Machine-Rolled Cigars and Smoking Tobacco declined. The company narrowed its full-year guidance.

Nov.12 by 2FIRSTS.ai

Singapore Schools Enhance Anti-E-cigarette Education with Scenario Discussions and Scientific Evidence

Singapore schools are ramping up anti-vaping education through Character and Citizenship Education (CCE) and science lessons. Classes now use scenario-based discussions—for example, a friend asking you to hide their vape during a random bag check—to help students practise refusal, empathy and seeking help safely.

Oct.22 by 2FIRSTS.ai

China Announces Crackdown on Illegal Nicotine Pouch Manufacturing Involving Counterfeit VELO, ZYN, and PABLO Products

The case is valued at approximately 400,000 yuan, and two suspects have been taken into custody.Video footage released by authorities shows that the counterfeit products involved well-known market brands such as VELO, ZYN, and PABLO.